• レポートコード:MRC2102QY16793 • 出版社/出版日: / 2021年1月 • レポート形態:英文、PDF、149ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:材料、化学 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のゾフェノプリル市場について種類別(純度98%、純度99%、その他)、用途別(化学工業、製薬業)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ゾフェノプリル市場の概要 ・世界の主要地域別ゾフェノプリル市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のゾフェノプリル市場規模2015-2026:種類別(純度98%、純度99%、その他) ・世界のゾフェノプリル市場規模2015-2026:用途別(化学工業、製薬業) ・ゾフェノプリルの米国市場規模2015-2020 ・ゾフェノプリルのヨーロッパ市場規模2015-2020 ・ゾフェノプリルの中国市場規模2015-2020 ・ゾフェノプリルの日本市場規模2015-2020 ・ゾフェノプリルの東南アジア市場規模2015-2020 ・ゾフェノプリルのインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・ゾフェノプリルの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ゾフェノプリルの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Zofenopril (CAS 81872-10-8) Market
The global Zofenopril (CAS 81872-10-8) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Zofenopril (CAS 81872-10-8) Scope and Market Size
The global Zofenopril (CAS 81872-10-8) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zofenopril (CAS 81872-10-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Zofenopril (CAS 81872-10-8) market is segmented into
Purity 98%
Purity 99%
Others
Segment by Application, the Zofenopril (CAS 81872-10-8) market is segmented into
Chemical Industry
Pharmaceutical Industry
The Zofenopril (CAS 81872-10-8) market is analysed and market size information is provided by regions (countries). Segment by Application, the Zofenopril (CAS 81872-10-8) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Zofenopril (CAS 81872-10-8) Market Share Analysis
Zofenopril (CAS 81872-10-8) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Zofenopril (CAS 81872-10-8) business, the date to enter into the Zofenopril (CAS 81872-10-8) market, Zofenopril (CAS 81872-10-8) product introduction, recent developments, etc.
The major vendors covered:
Waterstone Technology
Alfa Chemistry
Advanced Synthesis Technologies
2A PharmaChem
3B Scientific
City Chemicals
Nacalai Tesque
Pfaltz & Bauer
Kanto Chemical
Wako Pure Chemical Industries
LiangXiu Biotechnology
1 Zofenopril (CAS 81872-10-8) Market Overview
1.1 Zofenopril (CAS 81872-10-8) Product Scope
1.2 Zofenopril (CAS 81872-10-8) Segment by Type
1.2.1 Global Zofenopril (CAS 81872-10-8) Sales by Type (2020-2026)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Others
1.3 Zofenopril (CAS 81872-10-8) Segment by Application
1.3.1 Global Zofenopril (CAS 81872-10-8) Sales Comparison by Application (2020-2026)
1.3.2 Chemical Industry
1.3.3 Pharmaceutical Industry
1.4 Zofenopril (CAS 81872-10-8) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Zofenopril (CAS 81872-10-8) Sales Growth Rate (2015-2026)
1.4.2 Global Zofenopril (CAS 81872-10-8) Revenue and Growth Rate (2015-2026)
1.4.3 Global Zofenopril (CAS 81872-10-8) Price Trends (2015-2026)
2 Zofenopril (CAS 81872-10-8) Estimate and Forecast by Region
2.1 Global Zofenopril (CAS 81872-10-8) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Zofenopril (CAS 81872-10-8) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Zofenopril (CAS 81872-10-8) Sales Market Share by Region (2015-2020)
2.2.2 Global Zofenopril (CAS 81872-10-8) Revenue Market Share by Region (2015-2020)
2.3 Global Zofenopril (CAS 81872-10-8) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Zofenopril (CAS 81872-10-8) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Zofenopril (CAS 81872-10-8) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
2.4.2 Europe Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
2.4.3 China Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
2.4.4 Japan Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
2.4.6 India Zofenopril (CAS 81872-10-8) Estimates and Projections (2015-2026)
3 Global Zofenopril (CAS 81872-10-8) Competition Landscape by Players
3.1 Global Top Zofenopril (CAS 81872-10-8) Players by Sales (2015-2020)
3.2 Global Top Zofenopril (CAS 81872-10-8) Players by Revenue (2015-2020)
3.3 Global Zofenopril (CAS 81872-10-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zofenopril (CAS 81872-10-8) as of 2019)
3.4 Global Zofenopril (CAS 81872-10-8) Average Price by Company (2015-2020)
3.5 Manufacturers Zofenopril (CAS 81872-10-8) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Zofenopril (CAS 81872-10-8) Players (Opinion Leaders)
4 Global Zofenopril (CAS 81872-10-8) Market Size by Type
4.1 Global Zofenopril (CAS 81872-10-8) Historic Market Review by Type (2015-2020)
4.1.1 Global Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
4.1.2 Global Zofenopril (CAS 81872-10-8) Revenue Market Share by Type (2015-2020)
4.1.3 Global Zofenopril (CAS 81872-10-8) Price by Type (2015-2020)
4.2 Global Zofenopril (CAS 81872-10-8) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Zofenopril (CAS 81872-10-8) Sales Forecast by Type (2021-2026)
4.2.2 Global Zofenopril (CAS 81872-10-8) Revenue Forecast by Type (2021-2026)
4.2.3 Global Zofenopril (CAS 81872-10-8) Price Forecast by Type (2021-2026)
5 Global Zofenopril (CAS 81872-10-8) Market Size by Application
5.1 Global Zofenopril (CAS 81872-10-8) Historic Market Review by Application (2015-2020)
5.1.1 Global Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
5.1.2 Global Zofenopril (CAS 81872-10-8) Revenue Market Share by Application (2015-2020)
5.1.3 Global Zofenopril (CAS 81872-10-8) Price by Application (2015-2020)
5.2 Global Zofenopril (CAS 81872-10-8) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Zofenopril (CAS 81872-10-8) Sales Forecast by Application (2021-2026)
5.2.2 Global Zofenopril (CAS 81872-10-8) Revenue Forecast by Application (2021-2026)
5.2.3 Global Zofenopril (CAS 81872-10-8) Price Forecast by Application (2021-2026)
6 United States Zofenopril (CAS 81872-10-8) Market Facts & Figures
6.1 United States Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
6.2 United States Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
6.3 United States Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
7 Europe Zofenopril (CAS 81872-10-8) Market Facts & Figures
7.1 Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
7.2 Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
7.3 Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
8 China Zofenopril (CAS 81872-10-8) Market Facts & Figures
8.1 China Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
8.2 China Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
8.3 China Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
9 Japan Zofenopril (CAS 81872-10-8) Market Facts & Figures
9.1 Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Company (3015-3030)
9.2 Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
9.3 Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
10 Southeast Asia Zofenopril (CAS 81872-10-8) Market Facts & Figures
10.1 Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
11 India Zofenopril (CAS 81872-10-8) Market Facts & Figures
11.1 India Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
11.2 India Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
11.3 India Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Zofenopril (CAS 81872-10-8) Business
12.1 Waterstone Technology
12.1.1 Waterstone Technology Corporation Information
12.1.2 Waterstone Technology Business Overview
12.1.3 Waterstone Technology Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Waterstone Technology Zofenopril (CAS 81872-10-8) Products Offered
12.1.5 Waterstone Technology Recent Development
12.2 Alfa Chemistry
12.2.1 Alfa Chemistry Corporation Information
12.2.2 Alfa Chemistry Business Overview
12.2.3 Alfa Chemistry Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alfa Chemistry Zofenopril (CAS 81872-10-8) Products Offered
12.2.5 Alfa Chemistry Recent Development
12.3 Advanced Synthesis Technologies
12.3.1 Advanced Synthesis Technologies Corporation Information
12.3.2 Advanced Synthesis Technologies Business Overview
12.3.3 Advanced Synthesis Technologies Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Advanced Synthesis Technologies Zofenopril (CAS 81872-10-8) Products Offered
12.3.5 Advanced Synthesis Technologies Recent Development
12.4 2A PharmaChem
12.4.1 2A PharmaChem Corporation Information
12.4.2 2A PharmaChem Business Overview
12.4.3 2A PharmaChem Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 2A PharmaChem Zofenopril (CAS 81872-10-8) Products Offered
12.4.5 2A PharmaChem Recent Development
12.5 3B Scientific
12.5.1 3B Scientific Corporation Information
12.5.2 3B Scientific Business Overview
12.5.3 3B Scientific Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 3B Scientific Zofenopril (CAS 81872-10-8) Products Offered
12.5.5 3B Scientific Recent Development
12.6 City Chemicals
12.6.1 City Chemicals Corporation Information
12.6.2 City Chemicals Business Overview
12.6.3 City Chemicals Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 City Chemicals Zofenopril (CAS 81872-10-8) Products Offered
12.6.5 City Chemicals Recent Development
12.7 Nacalai Tesque
12.7.1 Nacalai Tesque Corporation Information
12.7.2 Nacalai Tesque Business Overview
12.7.3 Nacalai Tesque Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nacalai Tesque Zofenopril (CAS 81872-10-8) Products Offered
12.7.5 Nacalai Tesque Recent Development
12.8 Pfaltz & Bauer
12.8.1 Pfaltz & Bauer Corporation Information
12.8.2 Pfaltz & Bauer Business Overview
12.8.3 Pfaltz & Bauer Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfaltz & Bauer Zofenopril (CAS 81872-10-8) Products Offered
12.8.5 Pfaltz & Bauer Recent Development
12.9 Kanto Chemical
12.9.1 Kanto Chemical Corporation Information
12.9.2 Kanto Chemical Business Overview
12.9.3 Kanto Chemical Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kanto Chemical Zofenopril (CAS 81872-10-8) Products Offered
12.9.5 Kanto Chemical Recent Development
12.10 Wako Pure Chemical Industries
12.10.1 Wako Pure Chemical Industries Corporation Information
12.10.2 Wako Pure Chemical Industries Business Overview
12.10.3 Wako Pure Chemical Industries Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Wako Pure Chemical Industries Zofenopril (CAS 81872-10-8) Products Offered
12.10.5 Wako Pure Chemical Industries Recent Development
12.11 LiangXiu Biotechnology
12.11.1 LiangXiu Biotechnology Corporation Information
12.11.2 LiangXiu Biotechnology Business Overview
12.11.3 LiangXiu Biotechnology Zofenopril (CAS 81872-10-8) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 LiangXiu Biotechnology Zofenopril (CAS 81872-10-8) Products Offered
12.11.5 LiangXiu Biotechnology Recent Development
13 Zofenopril (CAS 81872-10-8) Manufacturing Cost Analysis
13.1 Zofenopril (CAS 81872-10-8) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Zofenopril (CAS 81872-10-8)
13.4 Zofenopril (CAS 81872-10-8) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Zofenopril (CAS 81872-10-8) Distributors List
14.3 Zofenopril (CAS 81872-10-8) Customers
15 Market Dynamics
15.1 Zofenopril (CAS 81872-10-8) Market Trends
15.2 Zofenopril (CAS 81872-10-8) Opportunities and Drivers
15.3 Zofenopril (CAS 81872-10-8) Market Challenges
15.4 Zofenopril (CAS 81872-10-8) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Zofenopril (CAS 81872-10-8) Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Zofenopril (CAS 81872-10-8) Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Zofenopril (CAS 81872-10-8) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Zofenopril (CAS 81872-10-8) Sales (K MT) by Region (2015-2020)
Table 5. Global Zofenopril (CAS 81872-10-8) Sales Market Share by Region (2015-2020)
Table 6. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Zofenopril (CAS 81872-10-8) Revenue Share by Region (2015-2020)
Table 8. Global Zofenopril (CAS 81872-10-8) Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Zofenopril (CAS 81872-10-8) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Zofenopril (CAS 81872-10-8) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Zofenopril (CAS 81872-10-8) (K MT) of Key Companies (2015-2020)
Table 13. Global Zofenopril (CAS 81872-10-8) Sales Share by Company (2015-2020)
Table 14. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Zofenopril (CAS 81872-10-8) Revenue Share by Company (2015-2020)
Table 16. Global Zofenopril (CAS 81872-10-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zofenopril (CAS 81872-10-8) as of 2019)
Table 17. Global Zofenopril (CAS 81872-10-8) Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Zofenopril (CAS 81872-10-8) Manufacturing Sites and Area Served
Table 19. Manufacturers Zofenopril (CAS 81872-10-8) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Zofenopril (CAS 81872-10-8) Players
Table 22. Global Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 23. Global Zofenopril (CAS 81872-10-8) Sales Share by Type (2015-2020)
Table 24. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Zofenopril (CAS 81872-10-8) Price (K MT) by Type (2015-2020)
Table 26. Global Zofenopril (CAS 81872-10-8) Sales Share by Type (2021-2026)
Table 27. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Zofenopril (CAS 81872-10-8) Revenue Share by Type (2021-2026)
Table 29. Global Zofenopril (CAS 81872-10-8) Price (K MT) by Type (2021-2026)
Table 30. Global Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 31. Global Zofenopril (CAS 81872-10-8) Sales Share by Application (2015-2020)
Table 32. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Zofenopril (CAS 81872-10-8) Price (K MT) by Application (2015-2020)
Table 34. Global Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2021-2026)
Table 35. Global Zofenopril (CAS 81872-10-8) Sales Share by Application (2021-2026)
Table 36. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Zofenopril (CAS 81872-10-8) Revenue Share by Application (2021-2026)
Table 38. Global Zofenopril (CAS 81872-10-8) Price (K MT) by Application (2021-2026)
Table 39. United States Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 40. United States Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 41. United States Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 42. United States Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 43. United States Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 44. United States Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
Table 45. Europe Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 46. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 47. Europe Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 48. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 49. Europe Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 50. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 51. China Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 52. China Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 53. China Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 54. China Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 55. China Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 56. China Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
Table 57. Japan Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 58. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 59. Japan Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 60. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 61. Japan Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 62. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
Table 69. India Zofenopril (CAS 81872-10-8) Sales (K MT) by Company (2015-2020)
Table 70. India Zofenopril (CAS 81872-10-8) Sales Market Share by Company (2015-2020)
Table 71. India Zofenopril (CAS 81872-10-8) Sales (K MT) by Type (2015-2020)
Table 72. India Zofenopril (CAS 81872-10-8) Sales Market Share by Type (2015-2020)
Table 73. India Zofenopril (CAS 81872-10-8) Sales (K MT) by Application (2015-2020)
Table 74. India Zofenopril (CAS 81872-10-8) Sales Market Share by Application (2015-2020)
Table 75. Waterstone Technology Corporation Information
Table 76. Waterstone Technology Description and Business Overview
Table 77. Waterstone Technology Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Waterstone Technology Zofenopril (CAS 81872-10-8) Product
Table 79. Waterstone Technology Recent Development
Table 80. Alfa Chemistry Corporation Information
Table 81. Alfa Chemistry Description and Business Overview
Table 82. Alfa Chemistry Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Alfa Chemistry Zofenopril (CAS 81872-10-8) Product
Table 84. Alfa Chemistry Recent Development
Table 85. Advanced Synthesis Technologies Corporation Information
Table 86. Advanced Synthesis Technologies Description and Business Overview
Table 87. Advanced Synthesis Technologies Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Advanced Synthesis Technologies Zofenopril (CAS 81872-10-8) Product
Table 89. Advanced Synthesis Technologies Recent Development
Table 90. 2A PharmaChem Corporation Information
Table 91. 2A PharmaChem Description and Business Overview
Table 92. 2A PharmaChem Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. 2A PharmaChem Zofenopril (CAS 81872-10-8) Product
Table 94. 2A PharmaChem Recent Development
Table 95. 3B Scientific Corporation Information
Table 96. 3B Scientific Description and Business Overview
Table 97. 3B Scientific Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. 3B Scientific Zofenopril (CAS 81872-10-8) Product
Table 99. 3B Scientific Recent Development
Table 100. City Chemicals Corporation Information
Table 101. City Chemicals Description and Business Overview
Table 102. City Chemicals Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. City Chemicals Zofenopril (CAS 81872-10-8) Product
Table 104. City Chemicals Recent Development
Table 105. Nacalai Tesque Corporation Information
Table 106. Nacalai Tesque Description and Business Overview
Table 107. Nacalai Tesque Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Nacalai Tesque Zofenopril (CAS 81872-10-8) Product
Table 109. Nacalai Tesque Recent Development
Table 110. Pfaltz & Bauer Corporation Information
Table 111. Pfaltz & Bauer Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Pfaltz & Bauer Description and Business Overview
Table 113. Pfaltz & Bauer Zofenopril (CAS 81872-10-8) Product
Table 114. Pfaltz & Bauer Recent Development
Table 115. Kanto Chemical Corporation Information
Table 116. Kanto Chemical Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Kanto Chemical Description and Business Overview
Table 118. Kanto Chemical Zofenopril (CAS 81872-10-8) Product
Table 119. Kanto Chemical Recent Development
Table 120. Wako Pure Chemical Industries Corporation Information
Table 121. Wako Pure Chemical Industries Description and Business Overview
Table 122. Wako Pure Chemical Industries Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Wako Pure Chemical Industries Zofenopril (CAS 81872-10-8) Product
Table 124. Wako Pure Chemical Industries Recent Development
Table 125. LiangXiu Biotechnology Corporation Information
Table 126. LiangXiu Biotechnology Description and Business Overview
Table 127. LiangXiu Biotechnology Zofenopril (CAS 81872-10-8) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. LiangXiu Biotechnology Zofenopril (CAS 81872-10-8) Product
Table 129. LiangXiu Biotechnology Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Zofenopril (CAS 81872-10-8) Distributors List
Table 133. Zofenopril (CAS 81872-10-8) Customers List
Table 134. Zofenopril (CAS 81872-10-8) Market Key Trends
Table 135. Zofenopril (CAS 81872-10-8) Key Opportunities and Drivers
Table 136. Zofenopril (CAS 81872-10-8) Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Zofenopril (CAS 81872-10-8) Product Picture
Figure 2. Global Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Zofenopril (CAS 81872-10-8) Market Share by Application in 2020 & 2026
Figure 6. Chemical Industry Examples
Figure 7. Pharmaceutical Industry Examples
Figure 8. Global Zofenopril (CAS 81872-10-8) Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Zofenopril (CAS 81872-10-8) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Zofenopril (CAS 81872-10-8) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Zofenopril (CAS 81872-10-8) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Zofenopril (CAS 81872-10-8) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Zofenopril (CAS 81872-10-8) Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Zofenopril (CAS 81872-10-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Zofenopril (CAS 81872-10-8) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Zofenopril (CAS 81872-10-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Zofenopril (CAS 81872-10-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Zofenopril (CAS 81872-10-8) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Zofenopril (CAS 81872-10-8) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Zofenopril (CAS 81872-10-8) Players Market Share by Revenue in Zofenopril (CAS 81872-10-8) 2015 & 2019
Figure 26. Zofenopril (CAS 81872-10-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Zofenopril (CAS 81872-10-8) Revenue Share by Type (2015-2020)
Figure 28. Global Zofenopril (CAS 81872-10-8) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Zofenopril (CAS 81872-10-8) Revenue Share by Application (2015-2020)
Figure 30. Global Zofenopril (CAS 81872-10-8) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 32. United States Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 33. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Company in 2019
Figure 34. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 35. Europe Zofenopril (CAS 81872-10-8) Sales Market Share by Application in 2019
Figure 36. China Zofenopril (CAS 81872-10-8) Sales Market Share by Company in 2019
Figure 37. China Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 38. China Zofenopril (CAS 81872-10-8) Sales Market Share by Application in 2019
Figure 39. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Company in 2019
Figure 40. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 41. Japan Zofenopril (CAS 81872-10-8) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Zofenopril (CAS 81872-10-8) Sales Market Share by Application in 2019
Figure 45. India Zofenopril (CAS 81872-10-8) Sales Market Share by Company in 2019
Figure 46. India Zofenopril (CAS 81872-10-8) Sales Market Share by Type in 2019
Figure 47. India Zofenopril (CAS 81872-10-8) Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Zofenopril (CAS 81872-10-8)
Figure 50. Manufacturing Process Analysis of Zofenopril (CAS 81872-10-8)
Figure 51. Zofenopril (CAS 81872-10-8) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed